| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cornerstone Therapeutics Inc. (NASDAQ: CRTX)
CRTX Technical Analysis
1.5
| As on 3rd Feb 2014 CRTX Share Price closed @ 9.49 and we RECOMMEND Buy for LONG-TERM with Stoploss of 8.84 & Sell for SHORT-TERM with Stoploss of 9.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRTX Share Price
| Open | 9.48 | Change | Price | % |
| High | 9.54 | 1 Day | 0.01 | 0.11 |
| Low | 9.48 | 1 Week | 0.00 | 0.00 |
| Close | 9.49 | 1 Month | 0.00 | 0.00 |
| Volume | 163312 | 1 Year | 0.00 | 0.00 |
| 52 Week High 10.80 | 52 Week Low 5.93 | ||||
NASDAQ USA Most Active Stocks
| YHOO | 52.58 | 0.00% |
| FNFG | 10.18 | -0.20% |
| DELL | 13.86 | 0.22% |
| RFMD | 16.59 | -2.07% |
| MU | 44.31 | 6.39% |
| RIMM | 13.03 | 0.39% |
| BBEP | 0.12 | 0.00% |
| GTAT | 0.44 | 0.00% |
| SUSQ | 14.20 | -0.77% |
| INTC | 45.49 | 2.52% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CRTX Daily Charts |
CRTX Intraday Charts |
Whats New @ Bazaartrend |
CRTX Free Analysis |
|
|
CRTX Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 9.55 |
| RESISTANCE | 9.52 |
| SUPPORT | 9.46 |
| SUPPORT | 9.43 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
CRTX Target for Month August
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
CRTX Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
CRTX Target for Year 2021
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
Cornerstone Therapeutics Inc. ( NASDAQ USA Symbol : CRTX )
Sector : Consumer Durables Major Pharmaceuticals And Other Stocks in Same Sector
Sector : Consumer Durables Major Pharmaceuticals And Other Stocks in Same Sector
CRTX Business Profile
Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on commercializing products for the hospital, respiratory and related specialty markets. The Company�s promoted products include CUROSURF, ZYFLO CR, FACTIVE and SPECTRACEF. On December 30, 2011, the Company acquired Cardiokine, Inc., a specialty pharmaceutical company, focused on developing hospital products for cardiovascular indications. In March 2012, it acquired the North American product rights for FACTIVE (Gemifloxacin Mesylate) tablets. In June 2012, the Company acquired EKR Therapeutics, Inc. In February 2014, Chiesi Farmaceutici S.p.A acquired Cornerstone Therapeutics Inc.
